Hepatic excretory function in sepsis: Implications from biophotonic analysis of transcellular xenobiotic transport in a rodent model

Critical Care

Volumn 17, Issue 2, 2013, Pages

  Gonnert, Falk A ^a   Recknagel, Peter ^a   Hilger, Ingrid ^a   Claus, Ralf A ^a   Bauer, Michael ^a   Kortgen, Andreas ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DY 635; DYE; INDOCYANINE GREEN; UNCLASSIFIED DRUG; XENOBIOTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILE; CHOLESTASIS; CONTROLLED STUDY; DISEASE SEVERITY; DRUG CLEARANCE; DRUG EXCRETION; DRUG TRANSPORT; DRUG UPTAKE; FLUORESCENCE; FLUORESCENCE MICROSCOPY; HEPATIC TRANSCELLULAR TRANSPORT; IN VIVO STUDY; INJURY SEVERITY; LIVER CELL; LIVER FUNCTION; LIVER INJURY; LIVER PARENCHYMA; LIVER TOXICITY; MALE; MULTIPLE ORGAN FAILURE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; SEPSIS; SHAM PROCEDURE; ANIMAL; BILIARY EXCRETION; CHEMISTRY; LIGHT RELATED PHENOMENA; LIVER; METABOLISM; PATHOLOGY; PHYSIOLOGY; TRANSPORT AT THE CELLULAR LEVEL; WISTAR RAT;

ANIMALS; BIOLOGICAL TRANSPORT; HEPATOBILIARY ELIMINATION; LIVER; MALE; MODELS, ANIMAL; OPTICAL PHENOMENA; RATS; RATS, WISTAR; SEPSIS; XENOBIOTICS;

EID: 84875951661     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc12606     Document Type: Article

References (23)

1. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003, 348:1546-1554. 10.1056/NEJMoa022139, 12700374.
2. Kramer L, Jordan B, Druml W, Bauer P, Metnitz PG. Incidence and prognosis of early hepatic dysfunction in critically ill patients--a prospective multicenter study. Crit Care Med 2007, 35:1099-1104. 10.1097/01.CCM.0000259462.97164.A0, 17334250.
3. Stehr A, Ploner F, Traeger K, Theisen M, Zuelke C, Radermacher P, Matejovic M. Plasma disappearance of indocyanine green: a marker for excretory liver function?. Intensive Care Med 2005, 31:1719-1722. 10.1007/s00134-005-2826-7, 16231068.
4. Kortgen A, Paxian M, Werth M, Recknagel P, Rauchfuss F, Lupp A, Krenn CG, Müller D, Claus RA, Reinhart K, Settmacher U, Bauer M. Prospective assessment of hepatic function and mechanisms of dysfunction in the critically ill. Shock 2009, 32:358-365. 10.1097/SHK.0b013e31819d8204, 19197231.
5. Chand N, Sanyal AJ. Sepsis-induced cholestasis. Hepatology 2007, 45:230-241. 10.1002/hep.21480, 17187426.
6. Vanwijngaerden YM, Wauters J, Langouche L, Vander Perre S, Liddle C, Coulter S, Vanderborght S, Roskams T, Wilmer A, Van den Berghe G, Mesotten D. Critical illness evokes elevated circulating bile acids related to altered hepatic transporter and nuclear receptor expression. Hepatology 2011, 54:1741-1752. 10.1002/hep.24582, 21800341.
7. Recknagel P, Gonnert FA, Westermann M, Lambeck S, Lupp A, Rudiger A, Dyson A, Carré JE, Kortgen A, Krafft C, Popp J, Sponholz C, Fuhrmann V, Hilger I, Claus RA, Riedemann NC, Wetzker R, Singer M, Trauner M, Bauer M. Liver dysfunction and phosphatidylinositol-3-kinase signalling in early sepsis: experimental studies in rodent models of peritonitis. PLoS Med 2012, 9:e1001338. 10.1371/journal.pmed.1001338, 3496669, 23152722.
8. Oude Elferink RP, Jansen PL. The role of the canalicular multispecific organic anion transporter in the disposal of endo- and xenobiotics. Pharmacol Ther 1994, 64:77-97. 10.1016/0163-7258(94)90034-5, 7846117.
9. Szabo G, Romics L, Frendl G. Liver in sepsis and systemic inflammatory response syndrome. Clin Liver Dis 2002, 6:1045-1066. x, 10.1016/S1089-3261(02)00058-2, 12516206.
10. Krouzecky A, Radermacher P, Matejovic M. Acute liver injury and biomarkers: a biological lesson from indocyanine green. Shock 2009, 32:340-341. 10.1097/SHK.0b013e31819f629c, 19295496.
11. Bolder U, Ton-Nu HT, Schteingart CD, Frick E, Hofmann AF. Hepatocyte transport of bile acids and organic anions in endotoxemic rats: impaired uptake and secretion. Gastroenterology 1997, 112:214-225. 10.1016/S0016-5085(97)70238-5, 8978362.
12. Recknagel P, Claus RA, Neugebauer U, Bauer M, Gonnert FA. In vivo imaging of hepatic excretory function in the rat by fluorescence microscopy. J Biophotonics 2012, 5:571-581. 10.1002/jbio.201100118, 22271709.
13. Gonnert FA, Kunisch E, Gajda M, Lambeck S, Weber M, Claus RA, Bauer M, Kinne RW. Hepatic fibrosis in a long-term murine model of sepsis. Shock 2012, 37:399-407. 10.1097/SHK.0b013e31824a670b, 22266973.
14. Gonnert FA, Recknagel P, Seidel M, Jbeily N, Dahlke K, Bockmeyer CL, Winning J, Losche W, Claus RA, Bauer M. Characteristics of clinical sepsis reflected in a reliable and reproducible rodent sepsis model. J Surg Res 2011, 170:e123-134. 10.1016/j.jss.2011.05.019, 21737102.
15. Cherrick GR, Stein SW, Leevy CM, Davidson CS. Indocyanine green: observations on its physical properties, plasma decay, and hepatic extraction. J Clin Invest 1960, 39:592-600. 10.1172/JCI104072, 293343, 13809697.
16. Kortgen A, Recknagel P, Bauer M. How to assess liver function?. Curr Opin Crit Care 2010, 16:136-141. 10.1097/MCC.0b013e3283361813, 22534730.
17. Kullak-Ublick GA, Hagenbuch B, Stieger B, Wolkoff AW, Meier PJ. Functional characterization of the basolateral rat liver organic anion transporting polypeptide. Hepatology 1994, 20:411-416.
18. Lund M, Kang L, Tygstrup N, Wolkoff AW, Ott P. Effects of LPS on transport of indocyanine green and alanine uptake in perfused rat liver. Am J Physiol 1999, 277:G91-100.
19. Huang L, Vore M. Multidrug resistance p-glycoprotein 2 is essential for the biliary excretion of indocyanine green. Drug Metab Dispos 2001, 29:634-637.
20. Smith AJ, van Helvoort A, van Meer G, Szabo K, Welker E, Szakacs G, Varadi A, Sarkadi B, Borst P. MDR3 P-glycoprotein, a phosphatidylcholine translocase, transports several cytotoxic drugs and directly interacts with drugs as judged by interference with nucleotide trapping. J Biol Chem 2000, 275:23530-23539. 10.1074/jbc.M909002199, 10918072.
21. Kimura S, Yoshioka T, Shibuya M, Sakano T, Tanaka R, Matsuyama S. Indocyanine green elimination rate detects hepatocellular dysfunction early in septic shock and correlates with survival. Crit Care Med 2001, 29:1159-1163. 10.1097/00003246-200106000-00014, 11395594.
22. Sakka SG, Reinhart K, Meier-Hellmann A. Prognostic value of the indocyanine green plasma disappearance rate in critically ill patients. Chest 2002, 122:1715-1720. 10.1378/chest.122.5.1715, 12426276.
23. Kruger PS, Freir NM, Venkatesh B, Robertson TA, Roberts MS, Jones M. A preliminary study of atorvastatin plasma concentrations in critically ill patients with sepsis. Intensive Care Med 2009, 35:717-721. 10.1007/s00134-008-1358-3, 19034423.